University Hospitals of Leuven Achieves Cure HHT Center of Excellence Designation
Newly recognized international treatment center expands access to expert, coordinated care for people living with HHT
MONKTON, MD—Cure HHT is proud to announce that University Hospitals of Leuven has been officially recognized as an HHT Center of Excellence, expanding access to expert, coordinated care for people living with hereditary hemorrhagic telangiectasia (HHT).
This designation recognizes University Hospitals of Leuven as part of a global network of more than 50 Cure HHT Centers of Excellence. These centers are certified through a comprehensive evaluation process to ensure patients have access to experienced clinicians, appropriate screening and treatment protocols, and multidisciplinary care for the complex needs of HHT.
HHT is a genetic condition that can affect multiple organs, including the nose, lungs, brain, liver, and gastrointestinal tract. Because complications can be serious and symptoms often vary widely from person to person, timely diagnosis and expert care are essential.
“We are extremely proud that UZ Leuven has been recognized as an International Treatment Centre by Cure HHT,” said Chief Medical Officer University Hospitals Leuven Prof. Gert Van Assche. “This reflects the outstanding dedication of our multidisciplinary team, working together to provide highly specialized, patient-centered care for individuals and families affected by HHT.”
Multidisciplinary team members available to patients receiving care at University Hospitals of Leuven include:
- Clinical Geneticist
- Pediatricic hemato-oncologist
- Internist
- Cardiologist
- Hematologist
- Pulmonologist
- ENT and head and neck surgeon
- Interventional Radiology
- Pediatric Cardiologist
- Hepatologist
- Neurosurgeon
- Neurovascular Radiologist
- Dermatologist
University Hospitals of Leuven is currently accepting new patients and welcomes inquiries from patients, families, and referring providers. To learn more about the new center, please visit uzleuven.be/row or Cure HHT’s Center of Excellence listings.
About Cure HHT
Cure HHT is the leading patient advocacy organization dedicated to improving the lives of people affected by hereditary hemorrhagic telangiectasia through education, awareness, research, advocacy, and access to expert care. Cure HHT works to advance diagnosis, treatment, and scientific discovery while supporting a global community of patients, families, clinicians, and researchers.
In what country is this Center located?
Happy to hear that great news and I hope that can happen soon in London too
There are many people with similar issues around UK
How can you get treatment there, is it private- do you need a referral? HHT sufferer here.
An HHT patient can seek care at the newly designated University Hospitals Leuven HHT Center of Excellence in Belgium. The center is actively accepting new patients and welcomes inquiries from patients, families, and referring providers. We recommend that you contact the Center directly before scheduling and ask whether a referral is required for the specific department.
Here is our list of international treatment centers: https://curehht.org/understanding-hht/get-support/hht-treatment-centers/international-treatment-centers/
University Hospitals Leuven patient website: http://www.hhtbelgium.be
Please reach out if you have further questions.